AGP Executive Report
Last update: 11 hours agoMedical Licensing: Taiwan is investigating allegations that a doctor used a forged US medical degree to obtain a licence; the claims have not yet been verified. Drug Regulation: India is tightening oversight of prescription-medicine advertising and has capped trade margins on cancer drugs at 30%, a move expected to lower prices. Biotech and Imaging: China aims to develop at least five innovative drugs with annual global sales above US$1 billion by 2030. Separately, Midea has completed its acquisition of Italian medical-imaging company Esaote, expanding its healthcare business. Mental Health: Experts warn that shortages of mental-health professionals are limiting access to care, while India’s first transgender postgraduate doctor marks a milestone for inclusion in medical education. Regional Health Risks: Malaysia reports rising respiratory and conjunctivitis cases in haze-affected areas, and Japan’s flu cases have crossed the alert level.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
